Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras

被引:945
作者
Luckman, SP
Hughes, DE
Coxon, FP
Russell, RGG
Rogers, MJ
机构
[1] Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
[2] Univ Sheffield, Dept Human Metab & Clin Biochem, Sheffield, S Yorkshire, England
[3] Univ Sheffield, Dept Pathol, Sheffield, S Yorkshire, England
关键词
D O I
10.1359/jbmr.1998.13.4.581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonates are currently the most important class of antiresorptive drags used for the treatment of metabolic bone diseases, Although the molecular targets of bisphosphonates have not been identified, these compounds inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis, Bisphosphonates also induce apoptosis in mouse J774 macrophages in vitro, probably by the same mechanisms that lead to osteoclast apoptosis, We have found that, in J774 macrophages, nitrogen-containing bisphosphonates (such as alendronate, ibandronate, and risedronate) inhibit post-translational modification (prenylation) of proteins, including the GTP-binding protein Ras, with farnesyl or geranylgeranyl isoprenoid groups, Clodronate did not inhibit protein prenylation, Mevastatin, an inhibitor of 3-hydroxy-3-methylglutatyl (HMG)-CoA reductase and hence the biosynthetic pathway required for the production of farnesyl pyrophosphate and geranylgeranyl pyrophosphate, also caused apoptosis in J774 macrophages and murine osteoclasts in vitro, Furthermore, alendronate-induced apoptosis, like mevastatin-induced apoptosis, could be suppressed in J774 cells by the addition of farnesyl pyrophosphate or geranylgeranyl pyrophosphate, while the effect of alendronate on osteoclast number and bone resorption in murine calvariae in vitro could be overcome by the addition of mevalonic acid, These observations suggest that nitrogen-containing bisphosphonate drugs cause apoptosis following inhibition of post-translational prenylation of proteins such as Ras, It is likely that these potent antiresorptive bisphosphonates also inhibit bone resorption by preventing protein prenylation in osteoclasts and that enzymes of the mevalonate pathway or prenyl protein transferases are the molecular targets of the nitrogen-containing bisphosphonates. Furthermore, the data support the vie cv that clodronate acts by a different mechanism.
引用
收藏
页码:581 / 589
页数:9
相关论文
共 48 条
  • [1] Amin D, 1996, ARZNEIMITTEL-FORSCH, V46, P759
  • [2] AMIN D, 1992, J LIPID RES, V33, P1657
  • [3] SUSCEPTIBILITY TO APOPTOSIS IS DIFFERENTIALLY REGULATED BY C-MYC AND MUTATED HA-RAS ONCOGENES AND IS ASSOCIATED WITH ENDONUCLEASE AVAILABILITY
    ARENDS, MJ
    MCGREGOR, AH
    TOFT, NJ
    BROWN, EJH
    WYLLIE, AH
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1127 - 1133
  • [4] BOONEKAMP PM, 1986, BONE MINER, V1, P27
  • [5] Brown R. J., 1997, Bone (New York), V20, p115S
  • [6] BISPHOSPHONATES DIRECTLY INHIBIT THE BONE-RESORPTION ACTIVITY OF ISOLATED AVIAN OSTEOCLASTS INVITRO
    CARANO, A
    TEITELBAUM, SL
    KONSEK, JD
    SCHLESINGER, PH
    BLAIR, HC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) : 456 - 461
  • [7] P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID
    CASEY, PJ
    SOLSKI, PA
    DER, CJ
    BUSS, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) : 8323 - 8327
  • [8] COXON FP, 1996, J BONE MINER RES S1, V11, pS396
  • [9] COXON FP, 1997, J BONE MINER RES, V12, P1526
  • [10] Danesi R, 1996, MOL PHARMACOL, V49, P972